Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy (Q43821134)
Jump to navigation
Jump to search
scientific article published in January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy |
scientific article published in January 2002 |
Statements
1 reference
Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy (English)
1 reference
R E Brown
1 reference
R A Henderson
1 reference
D Koster
1 reference
J Hutton
1 reference
M L Simoons
1 reference
1 January 2002
1 reference
1 reference
23
1 reference
1
1 reference
50-58
1 reference
Identifiers
1 reference
1 reference